DeNTS: Clinical Decision Support in Non-typhoidal Salmonella Bloodstream Infections in Children

Sponsor
Institute of Tropical Medicine, Belgium (Other)
Overall Status
Completed
CT.gov ID
NCT04473768
Collaborator
KU Leuven (Other), Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo (Other), Hôpital St. Luc Kisantu, République Democratique du Congo (Other), International Vaccine Institute (Other)
1,880
1
12
157.2

Study Details

Study Description

Brief Summary

In sub-Saharan Africa, non-typhoidal Salmonella (NTS) are a frequent cause of bloodstream infection, display high levels of antibiotic resistance and have a high case fatality rate (15%). In Kisantu hospital in the Democratic Republic of Congo (DR Congo), NTS account for 75% of bloodstream infection in children and many children are co-infected with Plasmodium falciparum (Pf) malaria. NTS bloodstream infection presents as a non-specific severe febrile illness, which challenges early diagnosis and, as a consequence, prompt and appropriate antibiotic treatment.Moreover, at the first level of care, frontline health workers have limited expertise and diagnostic skills and, as a consequence, clinical danger signs that indicate serious bacterial infections are often overlooked.

Basic handheld diagnostic instruments and point-of-care tests can help to reliably detect danger signs and improve triage, referral and the start of antibiotics, but there is need for field implementation and adoption to low-resource settings. Further, it is known that some clinical signs and symptoms are frequent in NTS bloodstream infections. The integration of these clinical signs and symptoms in a clinical decision support model can facilitate the diagnosis of NTS bloodstream infections and target antibiotic treatment.

The investigators aim to develop such a clinical decision support model based on data from children under five years old admitted to Kisantu district referral hospital in the Democratic republic of the Congo. While developing the model, the investigators will focus on the signs and symptoms that can differentiate NTS bloodstream infection from severe Pf malaria and on the clinical danger signs that can be assessed by handheld diagnostic instruments and point-of-care tests. The deliverable will be a clinical decision support model ready to integrate in an electronic decision support system.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    1880 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Clinical Decision Support in Non-typhoidal Salmonella Bloodstream Infections in Children in Sub-Saharan Africa: a Prospective Cohort Study
    Actual Study Start Date :
    Feb 1, 2021
    Actual Primary Completion Date :
    Jan 31, 2022
    Actual Study Completion Date :
    Jan 31, 2022

    Arms and Interventions

    Arm Intervention/Treatment
    NTS bloodstream infection

    growth of NTS in blood culture

    NTS/Pf malaria co-infection

    concurrence of current Pf malaria infection and NTS bloodstream infection

    Other pathogen bloodstream infections

    growth of a pathogen other than NTS in blood culture

    Severe Pf malaria mono-infection

    defined according to WHO-criteria

    Other causes of febrile illness requiring hospital admission

    Current Pf malaria infection: see above Recent Pf malaria infection: see above Non-confirmed bloodstream infection without Pf malaria: no growth in blood culture and negative results in all Pf malaria tests If feasible, severe bacterial localized infections such as pneumonia, meningitis, osteomyelitis, complicated urinary tract infection, abscess, skin/soft tissue infection or abdominal infection, will be assessed and clinically defined

    Outcome Measures

    Primary Outcome Measures

    1. Predictive signs and symptoms [12 months]

      Identify clinical signs and symptoms predictive for and differentiate between: 1.1. NTS bloodstream infection 1.2. severe Pf malaria mono-infection 1.3. NTS/Pf malaria co-infection 1.4. other-pathogen bloodstream infections 1.5. other causes of febrile illness requiring hospital admission

    2. Contribution of handheld diagnostics and point-of-care tests to NTS bloodstream infection diagnosis [12 months]

      Assess the contribution of handheld diagnostic instruments and point-of-care tests to the detection of danger signs associated with NTS bloodstream infection

    3. Clinical decision support model for NTS bloodstream infection [12 months]

      Develop a clinical decision support model for diagnosis of NTS bloodstream infection based on the predictive clinical signs and symptoms associated with NTS bloodstream infections

    Secondary Outcome Measures

    1. Contribution of handheld diagnostics and point-of-care tests to bloodstream infection diagnosis [12 months]

      Assess the contribution of handheld diagnostic instruments and point-of-care tests to the detection of danger signs associated with all pathogen bloodstream infection (NTS and other-pathogen bloodstream infections combined)

    2. Clinical decision support model for bloodstream infection [12 months]

      Develop a clinical decision support model for diagnosis of bloodstream infection caused by all pathogens (NTS and other pathogens combined)

    3. Case fatality [12 months]

      Determine the clinical signs and symptoms associated with case fatality in NTS bloodstream infection and all pathogen bloodstream infections (NTS and other pathogen combined)

    4. Geographical clustering [12 months]

      Assess the geographical clustering of cases with NTS bloodstream infection

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    28 Days to 5 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Be a child of > 28 days and < 5 years old

    2. Be admitted to Kisantu Hospital

    3. Having a blood cultured sampled according to the criteria for suspected bloodstream infection embedded in the blood culture surveillance, i.e. presence of objective fever, hypothermia or history of fever during past 48 hours + at least one of the following criteria:

    • Hypotension, confusion or increased respiratory rate

    • Suspicion of severe localized infection: pneumonia, meningitis, osteomyelitis, complicated urinary tract infection, abscess, skin/soft tissue infection or abdominal infection

    • Suspicion of typhoid fever

    • Suspicion of severe Pf malaria

    1. Having a caregiver willing and able to provide written informed consent
    Exclusion Criteria:
    • None

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Kisantu general referral hospital Antwerp Belgium 2000

    Sponsors and Collaborators

    • Institute of Tropical Medicine, Belgium
    • KU Leuven
    • Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo
    • Hôpital St. Luc Kisantu, République Democratique du Congo
    • International Vaccine Institute

    Investigators

    • Principal Investigator: Bieke Tack, MD, Institute of Tropical Medicine

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Institute of Tropical Medicine, Belgium
    ClinicalTrials.gov Identifier:
    NCT04473768
    Other Study ID Numbers:
    • ID ITM202007
    First Posted:
    Jul 16, 2020
    Last Update Posted:
    Apr 5, 2022
    Last Verified:
    Apr 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Institute of Tropical Medicine, Belgium
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 5, 2022